JAMA Network
What The Study Did: Researchers analyzed the price differences between capsule and tablet or ointment and cream forms of prescription drugs for insured patients and estimated the savings from shifting to a lower-cost formulation.
Authors: Sunita M. Desai, Ph.D., of the NYU School of Medicine in New York, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamahealthforum.2021.4823)
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
